drugset / Trial / NCT05382494

Intranasal Steroid as Medical Therapy For Sleep-Disordered Breathing in Children

NCT05382494

RandomizedParallel-groupQuadruple-blindTreatment

Summary

MIST+ is studying a nasal spray to see if it will reduce the need for surgery for snoring. Children aged 3-12 are invited to take part. Snoring affects up to 10% of children and can cause sleeping problems and concentration or behavioural issues in the daytime. Currently the most common treatment for snoring is surgery to remove the tonsils and/or adenoids, however many children wait a long time to see a specialist. This research is trying to find if nasal sprays can help children with snoring, and whether this can reduce the need for surgery.

Timeline

Start
2022-12-05
Primary completion
2025-07-17
Completion
2025-07-17

Drugs

EvaluationDrugModalityDoseRoute
Subject Mometasone furoate Other / unclassified 50 ug Intranasal